We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$342M
AUM Growth
+$51.1M
Cap. Flow
+$47.6M
Cap. Flow %
13.91%
Top 10 Hldgs %
10.44%
Holding
675
New
141
Increased
130
Reduced
57
Closed
344

Sector Composition

Rank Sector Weight
1 Technology 15.97%
2 Industrials 12.49%
3 Consumer Discretionary 11.9%
4 Healthcare 11.63%
5 Consumer Staples 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALXN
601
DELISTED
Alexion Pharmaceuticals
ALXN
-10,903
Closed -$1.27M
WDR
602
DELISTED
Waddell & Reed Financial, Inc.
WDR
-11,200
Closed -$193K
FIT
603
DELISTED
Fitbit, Inc. Class A common stock
FIT
-14,592
Closed -$178K
WPX
604
DELISTED
WPX Energy, Inc.
WPX
-85,924
Closed -$800K
DNKN
605
DELISTED
Dunkin' Brands Group, Inc.
DNKN
-1,600
Closed -$70K
GPOR
606
DELISTED
Gulfport Energy Corp.
GPOR
-11,313
Closed -$354K
MNK
607
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
-15
Closed -$1K
NBL
608
DELISTED
Noble Energy, Inc.
NBL
-27,804
Closed -$997K
LM
609
DELISTED
Legg Mason, Inc.
LM
-1,379
Closed -$41K
CHK
610
DELISTED
Chesapeake Energy Corporation
CHK
0
MLNX
611
DELISTED
Mellanox Technologies, Ltd.
MLNX
-13,700
Closed -$657K
GWR
612
DELISTED
Genesee & Wyoming Inc.
GWR
-4,500
Closed -$265K
ONCE
613
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
-934
Closed -$48K
DF
614
DELISTED
Dean Foods Company
DF
-31,514
Closed -$570K
BID
615
DELISTED
Sotheby's
BID
-33,390
Closed -$915K
BMS
616
DELISTED
Bemis
BMS
-1,422
Closed -$73K
IDTI
617
DELISTED
Integrated Device Technology I
IDTI
-3,563
Closed -$72K
TFCF
618
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
-27,599
Closed -$752K
TAHO
619
DELISTED
Tahoe Resources Inc
TAHO
-100
Closed -$1K
ATHN
620
DELISTED
Athenahealth, Inc.
ATHN
-5,400
Closed -$745K
P
621
DELISTED
Pandora Media Inc
P
-10,436
Closed -$130K
IMPV
622
DELISTED
Imperva, Inc.
IMPV
-2,000
Closed -$86K
ESRX
623
DELISTED
Express Scripts Holding Company
ESRX
-22,970
Closed -$1.74M
ILG
624
DELISTED
ILG, Inc Common Stock
ILG
-18,835
Closed -$299K
PAY
625
DELISTED
Verifone Systems Inc
PAY
-46,009
Closed -$853K

Similar funds

Seven Eight Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Seven Eight Capital held 675 positions worth $342M, up 18% from $291M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Seven Eight Capital deployed $47.6M of net new capital in Q3 2016, opening 141 new positions and adding to 130 existing holdings. Its largest new stake was Teva Pharmaceuticals: 77,100 shares worth $3.55M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Mastercard, an estimated $2.55M trimmed.

  • Seven Eight Capital's largest Q3 2016 buy was Teva Pharmaceuticals: 77,100 shares worth $3.55M.
  • Seven Eight Capital added most to Bristol-Myers Squibb in Q3 2016, an estimated $3.69M increase.
  • Seven Eight Capital's biggest Q3 2016 reduction was Mastercard, cutting an estimated $2.55M.
  • Seven Eight Capital fully exited PNC Financial Services in Q3 2016, selling an estimated $3.04M.
  • Seven Eight Capital's ten largest holdings make up 10% of its $342M portfolio in Q3 2016.
  • Seven Eight Capital opened 141 new positions and closed 344 in Q3 2016.
  • Seven Eight Capital's portfolio value rose 18% quarter-over-quarter to $342M.

Based on Seven Eight Capital's 13F filing for Q3 2016, filed 14 Nov 2016.